Simon is recognised as an outstanding patent litigator with a top-tier practice advising global life sciences companies. He's the Head of our International Patents and UK Life Sciences groups. Simon specialises in contentious patent work in a variety of industries, but in particular for the life sciences sector. He's also highly experienced in pharmaceutical regulatory work.
Simon represents clients in the UK Patents Court, the UK Court of Appeal and at the European Patent Office, and regularly co-operates with lawyers conducting parallel litigation in the US and other European jurisdictions. He advises pharmaceutical clients on patent infringement and validity, launch strategy, preliminary injunction applications and pharmaceutical regulatory work. Outside of law, Simon lectures and writes regularly and is the UK correspondent of the Bioscience Law Review and the UK Contributor to Pharmaceutical, Biotechnology and Chemical Inventions (published by Oxford University Press).
Instructing Experts in Patent Litigation, co-author with Paul England, Bio-Science Law Review, Vol 13 Issue 5, 2013
Patent star
Intellectual property patent litigation - Band 3: “Simon Cohen is experienced and very good at coordinating.”
Life Sciences (IP/patent litigation) - Band 2: Simon Cohen is commended for his deft handling of patent revocation and SPC disputes. He regularly advises on and coordinates pan-European litigation strategies. "Simon Cohen is very thoughtful and clever."
Intellectual Property (patent litigation) - Band 3: Simon Cohen is highly regarded for his experience litigating patent disputes for life sciences companies. He is qualified to litigate before UK and European courts.
Life Sciences - IP/Patent Litigation: "Simon Cohen is commended for his deft handling of patent revocation and SPC disputes. He regularly advises on and coordinates pan-European litigation strategies."
Intellectual Property - Patent Litigation: "Simon Cohen is highly regarded for his experience litigating patent disputes for life sciences companies. He is qualified to litigate before UK and European courts."
IP - contentious and non-contentious
Leading individual - Life Sciences: IP/Patent litigation (Band 2): Simon Cohen is commended for his deft handling of patent revocation and SPC disputes. He regularly advises on and co-ordinates pan-European litigation strategies.
Leading individual - Intellectual Property: Patent litigation (Band 2): Simon Cohen is highly regarded for his experience litigating patent disputes for life sciences companies. He is qualified to litigate before UK and European courts.
Leading individual: litigation (Silver): Simon Cohen is “a fantastic professional, deeply strategic and familiar with how to put a great case together”. He is especially sought out for life sciences briefs.
Leading individual: Patents
Patent star
Leading individual - Intellectual Property: Patent Litigation (Band 2): Simon Cohen is a patent litigator with an enviable record running multi-jurisdictional disputes for life sciences companies. A source says he is "great fun to work with - he's relaxed and on top of the detail."
Leading individual - Life Sciences: IP/Patent Litigation (Band 2): Applauded for his "considerable life sciences experience," Simon Cohen is highly regarded for handling complex patent disputes. He is also noted for his pharmaceutical regulatory advice. Sources say he is "great fun to work with, relaxed and on top of the detail."
Leading individual - Intellectual Property: Patent Litigation (Band 2): Simon Cohen acts for leading life sciences companies in complex patent litigation. A market source says: "He is a really good planner and runs his team well."
Leading individual - Life Sciences: IP/Patent Litigation (Band 2): Simon Cohen is best known for co-ordinating complex patent disputes, although he also advises companies on securing market access for their treatments. A source says: "He has played strategic roles in cases covering every aspect of patent litigation and is a really good planner and organiser."
Apotex on the sale of six European subsidiaries in Belgium, Poland, the Netherlands, Czech Republic and Spain, to Aurobindo for EUR74 million. This highly complex transaction involved the share transfer of subsidiaries in multiple jurisdictions being co-ordinated and managed by our UK team. We simultaneously advised on a multitude of business separation, ongoing product supply agreements and IP licences for the European business to continue operating after being removed from the Apotex group.
by multiple authors
Cementing our position as expert international IP lawyers at the MIP EMEA IP Awards 2021
Paul England and Simon Cohen launch new life sciences IP guide
by Dr Paul England and Simon Cohen
by Adrian Toutoungi and Rochelle Ampomah-Ababio
by multiple authors
by multiple authors
by multiple authors
by multiple authors
by Alison Dennis and Alice Matthews
by Colin McCall and Charlie Adams